Skip to main content

Table 2 Stage I-IIA patients’ characteristics and clinical features

From: The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population

Parameters Group (no.) MST (mo) HR P
FIGO I (53) 69   
II (23) 49 2.291 (1.155–4.544) 0.018
Size 4 cm (44) 67   
>4 cm (32) 52 1.981 (0.997–3.937) 0.051
LNM No (46) 70   
Yes(22) 45 2.723 (1.294–5.729) 0.008
LVSI No (44) 69   
Yes (24) 46 2.367 (1.121–4.999) 0.024
DOI 2/3 (53) 66   
>2/3 (15) 32 2.102 (0.856–5.163) 0.105
NACT No (34) 63   
Yes (34) 61 1.111 (0.520–2.373) 0.785
Radiotherapy No (49) 61   
Yes (19) 37 1.864 (0.835–4.163) 0.129